Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
20.08
-2.33 (-10.40%)
Sep 23, 2026, 1:32 PM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.24 billion as of September 23, 2026. Its market cap has increased by 31,096.50% in one year.
Market Cap
1.24B
Enterprise Value
699.13M
1-Year Change
31,096.50%
Ranking
Category
Stock Price
$20.08
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.24B, an increase of 236.15%. That is a compound annual growth rate of 22.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.24B | 3,272.80% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 1.49B |
| ArriVent BioPharma | 1.47B |
| Bicara Therapeutics | 1.46B |
| Ultragenyx Pharmaceutical | 1.44B |
| Alpha Tau Medical | 1.43B |
| Avalyn Pharma | 1.40B |
| Latigo Biotherapeutics | 1.40B |
| First Tracks Biotherapeutics | 1.39B |